Michael Vidne
Michael Vidne
mv333@columbia.edu
Підтверджена електронна адреса в columbia.edu
Назва
Посилання
Посилання
Рік
A new look at state-space models for neural data
L Paninski, Y Ahmadian, DG Ferreira, S Koyama, KR Rad, M Vidne, ...
Journal of computational neuroscience 29 (1), 107-126, 2010
2282010
Modeling the impact of common noise inputs on the network activity of retinal ganglion cells
M Vidne, Y Ahmadian, J Shlens, JW Pillow, J Kulkarni, AM Litke, ...
Journal of computational neuroscience 33 (1), 97-121, 2012
1142012
Inferring synaptic inputs given a noisy voltage trace via sequential Monte Carlo methods
L Paninski, M Vidne, B DePasquale, DG Ferreira
Journal of computational neuroscience 33 (1), 1-19, 2012
512012
Spatial modes in a PCF fiber generated continuum
Y Vidne, M Rosenbluh
Optics express 13 (24), 9721-9728, 2005
342005
Inferring functional connectivity in an ensemble of retinal ganglion cells sharing a common input
M Vidne, J Kulkarni, Y Ahmadian, J Pillow, J Shlens, EJ Chichilnisky, ...
Frontiers in Computational Neuroscience, 248, 2009
182009
Comparison of ultrasonic and ophthalmoscopic evaluation of retinopathy of prematurity
DHK Jokl, RH Silverman, AD Springer, H Towers, S Kane, R Lopez, ...
Journal of Pediatric Ophthalmology & Strabismus 41 (6), 345-350, 2004
142004
CRISPR-Directed Gene Editing Catalyzes Precise Gene Segment Replacement In Vitro Enabling a Novel Method for Multiplex Site-Directed Mutagenesis
BM Sansbury, AM Wagner, G Tarcic, S Barth, E Nitzan, R Goldfus, ...
The CRISPR journal 2 (2), 121-132, 2019
122019
Not all RAS mutations created equal: Functional and clinical characterization of 80 different KRAS and NRAS mutations.
JM Loree, B Miron, V Holla, MJ Overman, AAL Pereira, M Lam, VK Morris, ...
Journal of Clinical Oncology 35 (15_suppl), 3589-3589, 2017
122017
Revisited analysis of a SHIVA 01 trial cohort using functional mutational analyses successfully predicted treatment outcome
M Kamal, G Tarcic, S Dureau, O Edelheit, Z Barbash, C Lecerf, C Morel, ...
Molecular oncology 12 (5), 594-601, 2018
62018
Robust particle filters via sequential pairwise reparameterized Gibbs sampling
L Paninski, KR Rad, M Vidne
2012 46th Annual Conference on Information Sciences and Systems (CISS), 1-6, 2012
52012
A novel high-throughput multispectral cell segmentation algorithm
J Golbstein, Y Tocker, R Sharivkin, G Tarcic, M Vidne
Annual conference on medical image understanding and analysis, 754-766, 2017
42017
A novel system for functional determination of variants of uncertain significance using deep convolutional neural networks
L Zimmerman, O Zelichov, A Aizenmann, Z Barbash, M Vidne, G Tarcic
Scientific reports 10 (1), 1-11, 2020
32020
A common-input model of a complete network of ganglion cells in the primate retina
M Vidne, Y Ahmadian, J Shlens, JW Pillow, J Kulkarni, EJ Chichilnisky, ...
Computational and Systems Neuroscience, 2010
32010
Functional mutational analysis to assess the oncogenic activity of variant of uncertain significance (VUS) detected in patients included in the SHIVA trial
G Tarcic, M Kamal, O Edelheit, Z Barbash, M Vidne, B Miron, C Callens, ...
European Journal of Cancer 1 (69), S6-S7, 2016
22016
Functional characterization of mutations and their interaction using the novel functional annotation for cancer treatment (FACT) platform
B Miron, N Peled, Z Barbash, O Edelheit, M Vidne, R Sharivkin, G Tarcic
Annals of Oncology 27, vi404, 2016
12016
Functional profiling of oncogenic mutations in lung cancer patients (NCT02274025)-interim results
B Miron, N Peled, G Tarcic, Z Barbash, O Edelheit, M Vidne, MR Kramer
Annals of Oncology 27, vi412, 2016
12016
Abstract CT212: Expanded phase 1/2a study of PLX8394, a novel next generation BRAF inhibitor in patients with advanced, unresectable solid tumors with alterations in BRAF
F Janku, E Sherman, R Yaeger, A Parikh, R Sullivan, L Feun, ...
Cancer Research 81 (13 Supplement), CT212-CT212, 2021
2021
Methods and systems for determining oncogenic index of patient specific mutations
G Tarcic, Y Altschuler, M Vidne
US Patent 11,015,229, 2021
2021
Functional measurement of mitogen-activated protein kinase pathway activation predicts responsiveness of RAS-mutant cancers to MEK inhibitors
S Kato, R Porter, R Okamura, S Lee, O Zelichov, G Tarcic, M Vidne, ...
European Journal of Cancer 149, 184-192, 2021
2021
Methods for in vitro site-directed mutagenesis using gene editing technologies
EB Kmiec, M Vidne, G Tarcic
US Patent App. 16/899,538, 2020
2020
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20